BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

XYTOS (XYTS) Establishes Partnership with DOVE Clinics


1/18/2011 10:20:53 AM

CARSON CITY, Nev.--(BUSINESS WIRE)--XYTOS, Inc. (the "Company") (OTC: XYTS) is very pleased to announce that we have established a partnership with DOVE Clinics based in the UK (www.doveclinic.com). Like XYTOS, DOVE has been working in several areas of Integrated Advanced Medical Procedures along with Conventional Medicine. In our December 7th 2010 News Release XYTOS updated the shareholders and referenced several points including the statement that the company has moved quickly to position itself to start treating patients in the United States with other geographic areas to be announced. In line with that announcement this partnership was established for several reasons; to name a couple. This is the first step in our business model to announce multiple locations globally for the XYTOS technology to be performed. In addition XYTOS will offer our patients additional advanced medical procedures (to be announced). The partnership will allow for a significant increase in revenues for XYTOS because European Patients interested in XYTOS can now be immediately treated in the UK rather than XYTOS losing patients that cannot travel to the States. Note that patients can reach us at patients@xytos.com

Read at BioSpace.com

XYTOS
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES